Assignee
SHANGHAI VITALGEN BIOPHARMA CO LTD
CN·5 granted patents·1 pending application·0 citations·filing 2023–2025
Top patents by PatentIndex Score
6 records- 0171US12371474B2Recombinant adeno-associated viral vectors for treating Bietti Crystalline DystrophySHANGHAI VITALGEN BIOPHARMA CO LTD·Filed 2024·Granted Jul 29, 2025·0 cites·15 claims
- 0265US12491266B2Recombinant AAV vectors for treating glutaric aciduria type ISHANGHAI VITALGEN BIOPHARMA CO LTD·Filed 2024·Granted Dec 9, 2025·0 cites·12 claims
- 0363US12522846B2Adeno-associated virus capsidSHANGHAI VITALGEN BIOPHARMA CO LTD·Filed 2024·Granted Jan 13, 2026·0 cites·12 claims
- 0458US2026091134A1Recombinant aav vectors for treating proteinopathies in central nervous systemSHANGHAI VITALGEN BIOPHARMA CO LTD·Filed 2025·Application pending·0 cites
- 0554US12496562B2Sinuous microstructure mixing unit and use thereofSHANGHAI VITALGEN BIOPHARMA CO LTD·Filed 2023·Granted Dec 16, 2025·0 cites·14 claims
- 0643US12509490B2AAV capsids for targeting nervous system and uses thereofSHANGHAI VITALGEN BIOPHARMA CO LTD·Filed 2025·Granted Dec 30, 2025·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI VITALGEN BIOPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →